Blumenauer Calls On Supreme Court To Review Historic Appeal Challenging The Constitutionality Of Federal Criminalization Of Cannabis

DISTRICT OF COLUMBIA:  U.S. Rep. Earl Blumenauer (D-OR), founder and co-chair of the Congressional Cannabis Caucus, called upon the U.S. Supreme Court to review and proceed with hearing Washington v. Barr, the most significant and potentially consequential cannabis-related lawsuit ever to be filed.

The Court will consider the plaintiffs’ appeal at a conference on Friday, October 9, and if the Court accepts the appeal for consideration, it could pave the way to federal legalization of cannabis for the first time since 1937, providing relief to millions of Americans who treat with medical marijuana to maintain their health and lives. If the Court were to decline to hear the appeal, the case would be over for good, resigning another generation of medical marijuana patients and the state-legal cannabis industry – which has invested billions in the state-legal market – to further legal uncertainty.

“The fact that nearly 94 percent of Americans support legalizing medical cannabis and yet it remains illegal at the federal level is a national disgrace,” said Blumenauer. “Furthermore, the laws and subsequent court decisions on cannabis are a mangled patchwork of contradictions. This case is an important opportunity to fix our failed national cannabis laws.”

In July 2020, the plaintiffs in Washington v. Barr filed their appeal with the U.S. Supreme Court, challenging the constitutionality of the federal criminalization of medical marijuana. The case was filed on behalf of five plaintiffs, including former NFL player Marvin Washington, Iraq War Veteran Jose Belen, 15-year-old Alexis Bortell, nine-year-old Jagger Cotte and the Cannabis Cultural Association.

As acknowledged by the District Court in this case, Alexis, Jagger and Specialist Belen are patients whose lives have been saved by medical cannabis. As reflected in the Complaint, Marvin Washington is a cannabis entrepreneur whose business would otherwise be eligible for federal funding through the Minority Business Enterprise program, but for his participation in the cannabis industry. The Cannabis Cultural Association seeks economic parity and social justice for persons of color who have been unfairly singled out for prosecution under the Controlled Substances Act and unjustly excluded economically from the state-legal cannabis industry.

Blumenauer along with seven federal lawmakers submitted an amicus brief in support of the plaintiff’s appeal. The case also has amicus brief support from 19 advocacy groups, including the National Organization for the Reform of Marijuana Laws (NORML), the International Cannabis Bar Association, National Cannabis Industry Association (NCIA), Last Prisoner Project, Minority Cannabis Business Association, and Americans For Safe Access.

Despite its legalization by 38 U.S. states and territories, cannabis is illegal at the federal level, creating insurmountable problems for patients around the country. Patients have lost their jobs, been expelled from colleges, and lost their professional licenses, even if state-legal jurisdictions, due to cannabis stigmatization wrought by federal prohibition.

While cannabis is also on the ballot in five states that will be voting on some form of cannabis legalization in November, adoption of legalization electorally on the state level will not solve the problems associated with federal prohibition. Rather, it would merely reinforce the absurdity of marijuana’s classification under Schedule I.

To read the full amicus brief filed on behalf of Blumenauer and his Congressional colleagues, click here.

House Approves Blumenauer Amendment To Protect Cannabis Programs

DISTRICT OF COLUMBIA:  As national support for federal marijuana legalization continues to climb, the U.S. House of Representatives today approved important legislation to protect state, territory, and tribal cannabis programs from federal interference.

The amendment, introduced by U.S. Reps. Earl Blumenauer (D-CO), Tom McClintock (R-CA), Eleanor Holmes Norton (D-DC), and Barbara Lee (D-CA), was approved 254–163 and would ensure legal cannabis programs in Oregon and dozens of other states, territories, and tribal lands are protected from Department of Justice intervention.

“The American people are demanding a change to our outdated cannabis laws and I am glad to see my colleagues heeding their calls,” Blumenauer, founder and co-chair of the Congressional Cannabis Caucus, said. “As we work to ultimately end the senseless prohibition of cannabis and the failed war on drugs, these amendments will help ensure the protection of legal state, territory and tribal cannabis programs.”

“For far too long, our federal cannabis policies have been rooted in our discriminatory past and have continued inflicting harm on communities of color. As the public’s views toward cannabis have evolved, Congress has a responsibility to ensure that our policies follow suit and move toward restorative justice,” Lee said. “I’m proud to have worked alongside Reps. Blumenauer, McClintock, and Holmes Norton on this crucial amendment to protect the progress states, tribes, and territories have made toward ending the discriminatory war on drugs.”

A copy of the amendment approved Thursday by the House can be found here.

And here’s a video of Blumenauer speaking in support of the amendment today on the House floor.

Congresswoman Barbara Lee Applauds Passage of Amendment to Protect State, Territory, and Tribal Cannabis Programs

DISTRICT OF COLUMBIA: Congresswoman Barbara Lee (CA-13), co-chair of the Congressional Cannabis Caucus, today applauded the passage of the Blumenauer, McClintock, Holmes Norton, Lee amendment to the Commerce, Justice, and Science Department funding bill. The measure, which would prevent the Department of Justice from using its funds to impede the implementation of cannabis programs in states, territories, and tribes, passed in a 254-163 vote. 

“For far too long, our federal cannabis policies have been rooted in our discriminatory past and have continued inflicting harm on communities of color. As the public’s views toward cannabis have evolved, Congress has a responsibility to ensure that our policies follow suit and move toward restorative justice,” said Congresswoman Barbara Lee. “I’m proud to have worked alongside Reps. Blumenauer, McClintock, and Holmes Norton on this crucial amendment to protect the progress states, tribes, and territories have made toward ending the discriminatory war on drugs.”

“The American people are demanding a change to our outdated cannabis laws and I am glad to see my colleagues heeding their calls,” said Rep. Blumenauer, founder and co-chair of the Congressional Cannabis Caucus. “As we work to ultimately end the senseless prohibition of cannabis and the failed war on drugs, these amendments will help ensure the protection of legal state, territory and tribal cannabis programs.”

Senator Harris, Colleagues Call On Congressional Leaders To Ensure Cannabis Small Businesses Can Access Emergency SBA Loan & Grant Programs

DISTRICT OF COLUMBIA: U.S. Senator Kamala D. Harris (D-CA) on Wednesday joined Senators Jacky Rosen (D-NV) and Ron Wyden (D-OR), and 7 of their Senate colleagues in sending a letter to Congressional leadership calling for forthcoming COVID-19 relief legislative packages to allow state-legal cannabis small businesses and indirect cannabis small businesses to access loan and emergency grant programs administered by the U.S. Small Business Administration (SBA).

In the letter, the Senators highlight the failings of current regulations that exclude small businesses with “direct” or “indirect” products or services that aid the use, growth, enhancement, or other development of cannabis from SBA-backed financing, including the Paycheck Protection Program (PPP) and Economic Injury Disaster Loans (EIDL). These outdated regulations have left taxpaying, state-legal cannabis small businesses behind during this crisis.

“The cannabis industry supports more than 240,000 workers in the United States, spanning 33 states and the District of Columbia. Some of these jobs have already been lost due to the COVID-19 pandemic and the resulting economic crisis, and there is significant risk of greater job loss in the coming months. Many cannabis businesses are small-to-medium size operators, and some have been ordered to close to comply with state public health safety measures without having access to the same support systems in place as other small businesses in different sectors,” wrote the Senators.

“Given the nature of the global COVID-19 pandemic, we must ensure that every American small business has the capacity to protect the health and economic wellbeing of their community and workforce. Therefore, we ask Senate Leadership to include in any future relief package provisions to allow state-legal cannabis small businesses and the small businesses who work with this industry to access the critical SBA support they need during these challenging and unprecedented times,” concluded the Senators.

In addition to Harris, Rosen, and Wyden, the letter was signed by Senators Catherine Cortez Masto (D-NV), Jeff Merkley (D-OR), Kirsten Gillibrand (D-NY), Bernie Sanders (D-VT), Ed Markey (D-MA), Elizabeth Warren (D-MA), and Michael Bennet (D-CO).

The full text of the letter can be found here and below:

Dear Majority Leader McConnell and Leader Schumer:

Thank you for your ongoing efforts to address the needs of the American people during the COVID-19 crisis. We write to ask that forthcoming COVID-19 relief legislation allow state-legal cannabis small businesses and indirect marijuana small businesses to access emergency loan and grant programs administered by the U.S. Small Business Administration (SBA). Access to the Paycheck Protection Program (PPP) and the Economic Injury Disaster Loan (EIDL) program will allow these small businesses to keep their workers on payroll and prevent further job losses that are devastating the economy. The coronavirus crisis demands relief for all workers and businesses, no matter the sector.

The cannabis industry supports more than 240,000 workers in the United States, spanning 33 states and the District of Columbia. Some of these jobs have already been lost due to the COVID-19 pandemic and the resulting economic crisis, and there is significant risk of greater job loss in the coming months. Many cannabis businesses are small-to-medium size operators, and some have been ordered to close to comply with state public health safety measures without having access to the same support systems in place as other small businesses in different sectors.

SBA’s current regulations exclude small businesses with “direct” or “indirect” products or services that aid the use, growth, enhancement, or other development of cannabis from SBA-backed financing, including PPP and EIDL. Consequently, small business owners in states with some form of legal cannabis must choose between remaining eligible for SBA loan programs, or doing business with or in a rapidly-growing and legal industry.

Workers at state-legal cannabis small businesses are no different from workers at any other small business—they show up to work every day, perform their duties, and most importantly, work to provide for their families. This lack of access to SBA assistance for cannabis small businesses will undoubtedly lead to unnecessary layoffs, reduced hours, pay cuts, and furloughs for the workers who need support the most. The COVID-19 outbreak is no time to permit outdated federal policy to stand in the way of the reality that state-legal cannabis small businesses are sources of economic growth and financial stability for thousands of workers and families.

Given the nature of the global COVID-19 pandemic, we must ensure that every American small business has the capacity to protect the health and economic wellbeing of their community and workforce. Therefore, we ask Senate Leadership to include in any future relief package provisions to allow state-legal cannabis small businesses and the small businesses who work with this industry to access the critical SBA support they need during these challenging and unprecedented times.

Thank you for your consideration of this request.

Sincerely,

Booker, Lee, Khanna Introduce Landmark Marijuana Justice Bill

Social justice bill would end the federal prohibition on marijuana, expunge records, and reinvest in communities most impacted by War on Drugs

DISTRICT OF COLUMBIA: U.S. Senator Cory Booker (D-NJ), a member of the Senate’s Judiciary Committee, Rep. Barbara Lee (D-CA), Co-Chair of the Congressional Cannabis Caucus, and Rep. Ro Khanna (D-CA), today reintroduced their landmark bill to end the federal prohibition on marijuana.

In the Senate, the bill is cosponsored by Senators Ron Wyden (D-OR), Kirsten Gillibrand (D-NY), Bernie Sanders (I-VT), Kamala Harris (D-CA), Jeff Merkley (D-OR), Elizabeth Warren (D-MA), and Michael Bennet (D-CO).

“The War on Drugs has not been a war on drugs, it’s been a war on people, and disproportionately people of color and low-income individuals,” said Booker. “The Marijuana Justice Act seeks to reverse decades of this unfair, unjust, and failed policy by removing marijuana from the list of controlled substances and making it legal at the federal level.”

“But it’s not enough to simply decriminalize marijuana. We must also repair the damage caused by reinvesting in those communities that have been most harmed by the War on Drugs. And we must expunge the records of those who have served their time. The end we seek is not just legalization, it’s justice.”

“The War on Drugs has destroyed lives, and no one continues to be hurt more than people of color and low-income communities,” said Wyden. “There is a desperate need not only to correct course by ending the failed federal prohibition of marijuana, but to right these wrongs and ensure equal justice for those who have been disproportionately impacted.”

“Millions of Americans’ lives have been devastated because of our broken marijuana policies, especially in communities of color and low-income communities,” said Gillibrand. “Currently, just one minor possession conviction can take away a lifetime of opportunities for jobs, education, and housing, tear families apart, and make people more vulnerable to serving time in jail down the road. It is shameful that my son would likely be treated very differently from one of his Black or Latino peers if he was caught with marijuana, and legalizing marijuana is an issue of morality and social justice. I’m proud to work with Senator Booker on this legislation to help fix decades of injustice caused by our nation’s failed drug policies.”

“As I said during my 2016 campaign, hundreds of thousands of people are arrested for possession of marijuana every single year,” said Sanders. “Many of those people, disproportionately people of color, have seen their lives negatively impacted because they have criminal records as a result of marijuana use. That has got to change. We must end the absurd situation of marijuana being listed as a Schedule 1 drug alongside heroin. It is time to decriminalize marijuana, expunge past marijuana convictions and end the failed war on drugs.”

“Marijuana laws in this country have not been applied equally, and as a result we have criminalized marijuana use in a way that has led to the disproportionate incarceration of young men of color. It’s time to change that,” said Harris. “Legalizing marijuana is the smart thing to do and the right thing to do in order to advance justice and equality for every American.”

“Marijuana should be legalized, and we should wipe clean the records of those unjustly jailed for minor marijuana crimes. By outlawing marijuana, the federal government puts communities of color, small businesses, public health and safety at risk.” said Warren.

“This long-overdue change will help bring our marijuana laws into the 21st century. It’s past time we bring fairness and relief to communities that our criminal justice system has too often left behind.” said Bennet.

“Communities of color and low-income communities have been devastated by the War on Drugs,” said Lee. “As Co-Chair of the Congressional Cannabis Caucus, I’m proud to sponsor legislation that would legalize marijuana at the federal level, address the disproportionate impact of prohibition on people of color by expunging criminal convictions, and promote equitable participation in the legal marijuana industry by investing in the communities hardest hit by the failed War on Drugs.”

“Communities of color have been disproportionately impacted by misguided marijuana policy for far too long,” said Khanna. “Rep. Lee, Sen. Booker, and I are proud to introduce this important legislation and deliver justice for so many Americans.”

The Marijuana Justice Act seeks to reverse decades of failed drug policy that has disproportionately impacted low-income communities and communities of color. Beyond removing marijuana from the list of controlled substances – making it legal at the federal level – the bill would also automatically expunge the convictions of those who have served federal time for marijuana use and possession offenses, and it would reinvest in the communities most impacted by the failed War on Drugs through a community fund. This community reinvestment fund could be used for projects such as job training programs, re-entry services, and community centers.

The bill would also incentivize states through the use of federal funds to change their marijuana laws if those laws were shown to have a disproportionate effect on low-income individuals and/or people of color.

By going further than simply rescheduling marijuana with expungement and community reinvestment, Booker, Lee, and Khanna’s bill is the most far-reaching marijuana legislation ever to be introduced in Congress.

The bill is retroactive and would apply to those already serving time behind bars for marijuana-related offenses, providing for a judge’s review of marijuana sentences.

Full text of the bill is here.

Background on Booker’s leadership on issues of marijuana and criminal justice:

Booker has seen the effects of our broken marijuana laws first-hand, dating back to his time as a tenant lawyer, City Council member, and Mayor of Newark, where he created the city’s first office of prisoner re-entry to help formerly incarcerated individuals re-integrate into their communities.

In the Senate, Booker was an outspoken critic of former Attorney General Jeff Sessions’ effort to revive the failed War on Drugs. Most recently, he pressed Trump’s newest pick for Attorney General, William Barr, on his stance on marijuana legalization and the Cole memo, winning a commitment from Barr to leave alone states that have already legalized marijuana.

In addition to the Marijuana Justice Act, Booker is the co-author of the bipartisan CARERS Act, which would allow patients to access medical marijuana in states where it’s legal without fear of federal prosecution, and the bipartisan REDEEM Act, which would allow nonviolent drug offenders to petition a court to seal and expunge their drug offenses, while automatically sealing, and in some cases expunging, the nonviolent records of juveniles. These reforms would reduce a major barrier that formerly incarcerated individuals face when attempting to rejoin society. He is also a cosponsor of the Fair Chance Act, which prohibits the federal government and federal contractors from asking about the criminal history of a job applicant prior to a conditional offer of employment. Earlier this month, the Fair Chance Act passed out of the Senate Homeland Security and Governmental Affairs Committee.

Blumenauer Announces Co-Chairs of Congressional Cannabis Caucus For 116th Congress

DISTRICT OF COLUMBIA: Representative Earl Blumenauer (OR-03), a leading advocate for cannabis policy reform and founder and co-chair of the Congressional Cannabis Caucus, today announced the launch of the Caucus for the 116th Congress. The Caucus leadership team includes Representative Barbara Lee (D-CA), who will become the first woman of color to Co-Chair the Caucus; Representative Dave Joyce (R-OH), who newly joins the leadership team; and returning Co-Chair, Representative Don Young (R-AK-At-Large).

The bipartisan Caucus provides a forum for members of the U.S. House of Representatives to discuss, learn, and work together to establish a better and more rational approach to federal cannabis policy.

“The Cannabis Caucus was the first of its kind to create a forum for elected officials to collaborate on ways to address our outdated federal marijuana laws” said Rep. Blumenauer. “Congress is clearly out of step with the American people on cannabis when national support for federal marijuana legalization is at an all-time high and we saw several states move toward legalization last November.”

“Over the last decade, I’ve worked to build understanding and consensus on the need for reform and our movement is cresting. I’m looking forward to working alongside Reps. Lee, Joyce and Young to build on the bipartisan work we’ve done to end the senseless federal prohibition on marijuana once and for all.”

“For far too long, communities of color and women have been left out of the conversation on cannabis. I am committed to ensuring that marijuana reform goes hand-in-hand with criminal justice reform so we can repair some of the harm of the failed War on Drugs. We must also work to build an industry that is equitable and inclusive of the communities most impacted by cannabis prohibition,” said Rep. Lee.

“I’m proud to join my colleagues in leading the effort to implement responsible, commonsense cannabis policies,” said Rep. Joyce. “It is critical that we protect the rights of the states across the country, like Ohio, that have already done so at the state level. The federal government’s interference in this arena has stifled important medical research, interfered with doctors and patients making treatment decisions and harmed state-legal businesses. I look forward to working with Congressman Blumenauer, Congressman Young and Congresswoman Lee to advance sensible cannabis reforms that will benefit our nation’s veterans, patients, and businesses across the country.”

“Since the initial launch of the Congressional Cannabis Caucus we’ve seen an exponential growth in interest, legislation, and membership many would not have expected”, said Rep. Young. “The idea of States’ Rights has been a central tenet of this movement and one that I believe will ultimately carry the day. I encourage all Members to join us in this debate and explore the varying issues.”

“It’s good to be back with Representative Blumenauer, showing that bipartisanship can still shine. I’d also like to welcome Representatives Joyce and Lee as Co-Chairs of this important Caucus and I know they’ll be as asset. They follow in the footsteps of former Representatives Rohrabacher and Polis, who helped make this all possible with their long standing advocacy and dedication and we wish them the best.”

 

House Passes Budget With Medical Cannabis Protection Amendment

Rohrabacher-Blumenauer Amendment will Protect Patients from AG Sessions until September 

DISTRICT OF COLUMBIA: After months of debate and continuing resolutions, the House of Representatives has passed its Appropriations package for the fiscal year of 2018. Unlike previous short term measures, this bill will fully fund the government through September 30, 2018. At over 2,200 pages the bill is a massive combination of funding outlays and policy. Due to the hard work of advocates the bill includes the text of the Rohrabacher-Blumenauer amendment.

The amendment, which has appeared in previous versions of the annual appropriations bill protects medical cannabis patients and programs from federal interference by the Department of Justice. Due to the recession of the Cole, Ogden, and other memos by Attorney General Sessions, this amendment is the only thing that prevents large-scale federal raids and prosecutions against businesses and individuals complying with state laws. The full text of the amendment is below:

SEC. 538. None of the funds made available under this Act to the Department of Justice may be used, with respect to any of the States of Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, and Wyoming, or with respect to the District of Columbia, Guam, or Puerto Rico, to prevent any of them from implementing their own laws that authorize the use, distribution, possession, or cultivation of medical marijuana.

Attorney General Jeff Sessions lobbied Congress to oppose the re-passage of the amendment. In a letter sent in May 2017, he told Congress:  “I believe it would be unwise for Congress to restrict the discretion of the Department to fund particular prosecutions, particularly in the midst of an historic drug epidemic and potentially long-term uptick in violent crime.”  Sessions has been a vocal adversary of medical cannabis. Patient advocates fear that without the protections granted by the CJS Medical Marijuana Amendment, Session would be able to shut down medical cannabis programs and the patients they serve.

“The inclusion of the CJS Amendment in the House budget shows that Congress knows it must protect medical cannabis patients from AG Sessions and his Department of Justice. We are extremely grateful to the sponsors, Congressman Rohrabacher and Congressman Blumenauer, and the other members that showed leadership on the issue.“said Steph Sherer, Executive Director for Americans for Safe Access. “Now we hope the Senate will feel the same. We are one step closer to knowing patients will now be protected for another year while we work on passing comprehensive legislation like the CARERS ACT.”

Support for the re-passage of the amendment was strong and diverse. In November 2017, 66 members of the House signed on to a letter to Congressional Leadership that expressed the desire to maintain protections for state medical cannabis programs. The letter was signed by 28 Republicans and 38 Democrats.

A similar letter was also sent last year to appropriations leadership signed by Americans for Safe Access, The Michael J. Fox Foundation, US Pain Foundation, National Multiple Sclerosis Society, Epilepsy Foundation, Tourette Association of America, National Women’s Health Network, and Realm of Caring.

The bill will now be sent to the Senate and  will be considered under a closed rule, meaning that the time of debate and ability to amend the bill will be limited. While a government shutdown remains possible over other policy provisions in the bill, it is incredibly encouraging to see the provisions of this amendment in the original text of the bill.

The bill also includes several provisions protecting industrial hemp, and a significant number of provisions related to combating the opioid crisis.

 

What Medical Cannabis Could Look Like For Our Veterans Forum

DISTRICT OF COLUMBIA:  In recent months, Americans nationwide have been faced with a startling awakening regarding opioid related overdoses and deaths. State legislatures and Congress alike are desperately seeking measures today that will address this unfolding epidemic. Meanwhile, the Department of Veteran’s Affairs is tasked with addressing near epidemic levels of not only Opioid related overdoses, but also opioid related suicides by America’s elite fighting forces and valued community of veterans.

“Within the US one person every 20 minutes dies of either an accidental and or intentional overdose to prescription pain medication. Doing the math that’s 3 every hour, 72 a day and so forth. It has been reported that our Veterans are overdosing at twice the rate of civilians….in other words 2 of the 3 causalities within the above hour time frame are Veterans,” says Jeffery Staker, a Marine veteran, DOD Firefighter, and founder of Hoosier Veterans for Medical Cannabis.

In a joint effort to address and cull this epidemic, several members of the Veteran Affairs Staff, the Congressional Cannabis Caucus, and Hoosier Veterans for Medical Cannabis have aligned to attend an intimate educational forum with the nations’ leading physicians. The forum will be held September 13th, from 12:00 – 2:00 p.m. at the Rayburn House Office Building, Gold Room, RM #2168.

“With veterans representing 7% percent of the American population, yet accounting for 20 percent of the national suicide rate, these numbers are unacceptable, and it is ‘all hands-on deck’ for all Americans to learn together and do more for those who selflessly serve our country,” said Brandon L. Wyatt, attorney and Army disabled combat veteran.

“We are excited to partner with the country’s top medical minds Donald Abrams, MD; Ziva D Cooper, PhD; Darryl Hudson, PhD; Mary Lynn Mathre, RN, MSH, CARN; and Jordan Tishler, MD; to raise awareness of the veterans’ suicide epidemic, explore arduous drug policies, and engage leaders in the government sector to professionally explore safer medical alternatives, in hopes to save lives every day,” said Staker, forum organizer.

“Veterans from all 50 states and US territories have fought tirelessly for freedom, in an academic setting, we are honored to address our injuries to continue to be of service to All Americans with the sincere hope of ending the opioid crisis”, Wyatt noted.

Joining the forum will be top Veteran advocate groups from across the country to include: Veterans Cannabis Group, Marijuana for Trauma, Veterans for Medical Cannabis Access, Hoosier Veterans for Medical Cannabis and Operation EVAC, along with the Veteran founded cannabis educational organization Patients Out of Time.

To RSVP Contact Hoosier Veterans For Medical Cannabis: hoosiervetsformc@gmail.com

 

Statement On The Formation Of The Cannabis Caucus

DISTRICT OF COLUMBIA: The nation’s leading cannabis and drug policy reform organizations commended Congressional members Thursday on the formation of the Congressional Cannabis Caucus.

Reps. Earl Blumenauer (D-OR), Dana Rohrabacher (R-CA), Jared Polis (D-CO), and Don Young (R-AK) formed the Congressional Cannabis Caucus to develop and promote sensible cannabis policy reform and work to ease the tension between federal and state cannabis laws.

They represent constituents in four of the eight states that have enacted laws regulating cannabis for medical and adult use. Twenty additional states have enacted comprehensive medical cannabis laws, and 16 additional states have enacted limited or unworkable medical cannabis laws. In total, 44 states have adopted laws rolling back cannabis prohibition at the state level, representing 95% of the U.S. House of Representatives and 88% of the Senate.

Joint statement on the formation of the Congressional Cannabis Caucus: 

“We commend Representatives Blumenauer, Rohrabacher, Polis, and Young for their leadership on the issue of cannabis policy. The establishment of a Cannabis Caucus will allow members from both parties, who represent diverse constituencies from around the country, to join together for the purpose of advancing sensible cannabis policy reform. It will also facilitate efforts to ease the tension between federal prohibition laws and state laws that regulate cannabis for medical and adult use.

“The formation of this caucus is a testament to how far our country has come on the issue of cannabis policy. There is a growing consensus that cannabis prohibition has failed, and it is time for a more sensible approach. A strong majority of Americans support making cannabis legal for medical and adult use, and an even stronger majority believes states should be able to establish their own cannabis policies without interference from the federal government. We look forward to working with caucus members to translate this growing public sentiment into sound public policy.”

Joint Statement by The National Organization For the Reform of Marijuana Laws (NORML), the Drug Policy Alliance, Students for Sensible Drug Policy, Americans for Safe Access, Marijuana Policy Project, the National Cannabis Industry Association, Law Enforcement Action Partnership, Doctors for Cannabis Regulation, and Clergy for a New Drug Policy.

For further comment, please contact the following organization representatives:

Justin Strekal, Political Director, NORML
202-483-5500, justin@norml.org

Michael Collins, Deputy Director National Affairs, Drug Policy Alliance
202-683-2981, mcollins@drugpolicy.org

Betty Aldworth, Executive Director, Students for Sensible Drug Policy
202-393-5280, betty@ssdp.org

Beth Collins, Senior Director of Government Relations and External Affairs, Americans for Safe Access
202-857-4272, beth@safeaccessnow.org

Robert Capecchi, Director of Federal Policies, Marijuana Policy Project
651-492-1739, rcapecchi@mpp.org

Taylor West, Deputy Director, National Cannabis Industry Association
303-223-3585, taylor@thecannabisindustry.org

Mikayla Hellwich, Media Relations Director, Law Enforcement Action Partnership
240-461-3066, mikayla@lawenforcementaction.org

Brian Muraresku, Executive Director and Counsel, Doctors for Cannabis Regulation
202-930-0097, bmuraresku@dcfr.org

Rev. Al Sharp, Executive Director, Clergy for a New Drug Policy
773-494-0420, revaesharp@gmail.com